These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8606801)

  • 1. Transport of histamine by vesicular monoamine transporter-2.
    Merickel A; Edwards RH
    Neuropharmacology; 1995 Nov; 34(11):1543-7. PubMed ID: 8606801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2.
    Finn JP; Edwards RH
    J Biol Chem; 1997 Jun; 272(26):16301-7. PubMed ID: 9195934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of residues involved in substrate recognition by a vesicular monoamine transporter.
    Merickel A; Rosandich P; Peter D; Edwards RH
    J Biol Chem; 1995 Oct; 270(43):25798-804. PubMed ID: 7592763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reserpine- and tetrabenazine-sensitive transport of (3)H-histamine by the neuronal isoform of the vesicular monoamine transporter.
    Erickson JD; Eiden LE; Schafer MK; Weihe E
    J Mol Neurosci; 1995; 6(4):277-87. PubMed ID: 8860238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine.
    Peter D; Vu T; Edwards RH
    J Biol Chem; 1996 Feb; 271(6):2979-86. PubMed ID: 8621690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of two vesicular monoamine transporters.
    Peter D; Liu Y; Sternini C; de Giorgio R; Brecha N; Edwards RH
    J Neurosci; 1995 Sep; 15(9):6179-88. PubMed ID: 7666200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2.
    Finn JP; Edwards RH
    J Biol Chem; 1998 Feb; 273(7):3943-7. PubMed ID: 9461580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential quantal release of histamine and 5-hydroxytryptamine from mast cells of vesicular monoamine transporter 2 knockout mice.
    Travis ER; Wang YM; Michael DJ; Caron MG; Wightman RM
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):162-7. PubMed ID: 10618388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.
    Erickson JD; Schafer MK; Bonner TI; Eiden LE; Weihe E
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5166-71. PubMed ID: 8643547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter.
    Zucker M; Weizman A; Rehavi M
    Life Sci; 2001 Sep; 69(19):2311-7. PubMed ID: 11669473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.
    Schütz B; Schäfer MK; Eiden LE; Weihe E
    Brain Res Dev Brain Res; 1998 Mar; 106(1-2):181-204. PubMed ID: 9555003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of a vesicular monoamine transporter by casein kinase II.
    Krantz DE; Peter D; Liu Y; Edwards RH
    J Biol Chem; 1997 Mar; 272(10):6752-9. PubMed ID: 9045708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules.
    Henry JP; Botton D; Sagne C; Isambert MF; Desnos C; Blanchard V; Raisman-Vozari R; Krejci E; Massoulie J; Gasnier B
    J Exp Biol; 1994 Nov; 196():251-62. PubMed ID: 7823026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours.
    Jakobsen AM; Andersson P; Saglik G; Andersson E; Kölby L; Erickson JD; Forssell-Aronsson E; Wängberg B; Ahlman H; Nilsson O
    J Pathol; 2001 Nov; 195(4):463-72. PubMed ID: 11745679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charged residues in transmembrane domains II and XI of a vesicular monoamine transporter form a charge pair that promotes high affinity substrate recognition.
    Merickel A; Kaback HR; Edwards RH
    J Biol Chem; 1997 Feb; 272(9):5403-8. PubMed ID: 9038139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuronal monoamine transporter VMAT2 is regulated by the trimeric GTPase Go(2).
    Höltje M; von Jagow B; Pahner I; Lautenschlager M; Hörtnagl H; Nürnberg B; Jahn R; Ahnert-Hilger G
    J Neurosci; 2000 Mar; 20(6):2131-41. PubMed ID: 10704487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cells.
    Hussain I; Bate GW; Henry J; Djali P; Dimaline R; Dockray GJ; Varro A
    J Physiol; 1999 Jun; 517 ( Pt 2)(Pt 2):495-505. PubMed ID: 10332097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histidine-419 plays a role in energy coupling in the vesicular monoamine transporter from rat.
    Shirvan A; Laskar O; Steiner-Mordoch S; Schuldiner S
    FEBS Lett; 1994 Dec; 356(1):145-50. PubMed ID: 7988710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain.
    Vilpoux C; Leroux-Nicollet I; Naudon L; Raisman-Vozari R; Costentin J
    Neuropharmacology; 2000 Apr; 39(6):1075-82. PubMed ID: 10727718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel, inhibitory action of amiodarone on vesicular monoamine transport.
    Haikerwal D; Dart AM; Little PJ; Kaye DM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):834-7. PubMed ID: 9918596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.